Pfizer: all 4,072 studies
Page 4 of 41. Open to participants first (153), then studies with results posted, then the rest; newest registration first within each.
- Real-World Effectiveness of Palbociclib in Combination With an Aromatase InhibitorCompletedNCT05361655Results posted
- A Study to Understand the Effect of Low-Fat and High-Fat Meals on the Medicine Called PF-07284890 in Healthy AdultsCompletedNCT05349864Phase 1Results posted
- A Study to Learn About the Study Medicine PF-07321332 and Ritonavir in Adult Healthy Chinese Participants.CompletedNCT05339334Phase 1Results posted
- A Study to Describe the Safety of a Vaccine (Called 13vPnC) in Healthy People 18 to 49 Years of Age in IndiaCompletedNCT05329259Phase 4Results posted
- Safety and Effectiveness of Apixaban Compared to Warfarin in Secondary Prevention in Patients With Atrial FibrillationCompletedNCT05321810Results posted
- Safety and Immunogenicity of RSVpreF Coadministered With SIIV in Adults ≥65 Years of AgeCompletedNCT05301322Phase 3Results posted
- Study to Evaluate Chronic Myeloid Leukemia Treatment Landscape and Real-life Treatment Outcomes in Hungary: Analysis of National Health Insurance Fund DatabaseCompletedNCT05286528Results posted
- A Study To Evaluate The Pharmacokinetics, Excretion, Mass Balance and Metabolism of PF-07265803CompletedNCT05286281Phase 1Results posted
- Relative Bioavailability Study of PF-07321332/Ritonavir Oral Powder Relative to the Commercial Tablets in Healthy ParticipantsCompletedNCT05263921Phase 1Results posted
- A Study to Learn About PAXLOVID (a Commercial Medicine) In People With COVID-19CompletedNCT05263908Results posted
- Relative Bioavailability Study of 4 Different Formulations of PF-07321332 Relative to the Commercial Tablet FormulationCompletedNCT05263895Phase 1Results posted
- Safety and Efficacy of BHV-3000 (Rimegepant) Orally Disintegrating Tablet for Acute Treatment of Temporomandibular DisordersTerminatedNCT05262517Phase 3Results posted
- Study of Maplirpacept (PF-07901801) in Combination With PLD in Patients With Platinum-Resistant Ovarian CancerTerminatedNCT05261490Phase 1/2Results posted
- Comparative Effectiveness of Targeted Therapies in BRAF Positive Metastatic Melanoma in the USCompletedNCT05260684Results posted
- A Study to Learn About The Study Medicine (Called PF-06823859) in Healthy Chinese ParticipantsCompletedNCT05257798Phase 1Results posted
- A Study to Learn About Abrocitinib in Adult Patients With Moderate to Severe Atopic DermatitisTerminatedNCT05250115Results posted
- Safety and Efficacy of BHV-3000 (Rimegepant) Orally Disintegrating Tablet for the Acute Treatment of Chronic RhinosinusitisCompletedNCT05248997Phase 3Results posted
- Voxelotor Neurocognitive Function StudyTerminatedNCT05228834Phase 3Results posted
- A Study of Elranatamab (PF-06863135) in Chinese Participants With Refractory Multiple Myeloma.CompletedNCT05228470Phase 2Results posted
- Efficacy and Safety Study of Rimegepant in Episodic Migraine Prevention With Multiple Dosing RegimensCompletedNCT05217927Phase 4Results posted
- Safety and Tolerability Study of Daily Dosing Rimegepant in Episodic Migraine PreventionCompletedNCT05207865Phase 4Results posted
- A First-in-human Study of Multiple Doses of Topically Administered PF-07295324 and PF-07259955CompletedNCT05206604Phase 1Results posted
- A Study to Learn About the Study Medicine (Called Tofacitinib) in People With Psoriatic ArthritisCompletedNCT05195814Results posted
- Pharmacokinetic Comparability Study in Healthy Participants - PF-06881894 On-Body Injector Relative to Prefilled SyringeCompletedNCT05194579Phase 1Results posted
- An Extension Study for Participants Who Have Completed the Treatment Period of a Qualifying Parent StudyCompletedNCT05192200Phase 2Results posted
- Latin American Real-world Study in Acute LeukemiaCompletedNCT05166135Results posted
- Study of Multiple Oral Doses of PF-07081532 in Adult Participants With Type 2 Diabetes MellitusCompletedNCT05158244Phase 1Results posted
- Treatment Patterns And Clinical Outcomes Among Patients in Latin America Receiving First Line Palbociclib Combinations For HR+/HER2- Advanced/Metastatic Breast Cancer In Real World Settings.CompletedNCT05155566Results posted
- Real-world Treatment Patterns of Endocrine Based Therapy Among Patients With Hormone Receptor-positive/Human Epidermal Growth Factor Receptor-2-negative (HR+/HER2-) Advanced Breast Cancer: An Analysis of Administrative Claims Data in JapanCompletedNCT05153187Results posted
- Treatment Patterns and Clinical Outcomes Among Talazoparib-Treated Adults With HER2-Negative mBC With gBRCA1/2mCompletedNCT05141708Results posted
- A Study to Examine the Clinical Effectiveness of Tafamidis in Patients With Mixed Phenotype Hereditary Transthyretin AmyloidosisCompletedNCT05139680Results posted
- A Study to Assess the Hemodynamic Effects, Safety, Tolerability, and Pharmacokinetics of Intravenous APD418 in Adult Participants With Heart Failure With Reduced Ejection FractionTerminatedNCT05139615Phase 2Results posted
- A Study of Tucatinib or Placebo With Trastuzumab and Pertuzumab for Metastatic HER2+ Breast CancerActive, not recruitingNCT05132582Phase 3Results posted
- Food Effect Study to Evaluate the Effect of High-Fat Meal on the Relative Bioavailability of PF-07321332 Boosted With Ritonavir in Healthy Adult ParticipantsCompletedNCT05129475Phase 1Results posted
- A Target Occupancy Study With Ritlecitinib.CompletedNCT05128058Phase 1Results posted
- Continuation Study of Long-term Safety, Tolerability, Pharmacokinetics and Efficacy of Recifercept in AchondroplasiaTerminatedNCT05116046Phase 2Results posted
- A Study of PF-07258669 In Healthy Adult ParticipantsCompletedNCT05113940Phase 1Results posted
- Evaluation of the Pharmacokinetics, Safety and Tolerability of Single Dose of PF-06480605 in Chinese Healthy ParticipantsCompletedNCT05107492Phase 1Results posted
- Study to Evaluate the Effect of Multiple-Dose Ritlecitinib on the Pharmacokinetics (PK) of TolbutamideCompletedNCT05097716Phase 1Results posted
- Clinical Lot Consistency for RSVpreF in a Population of Healthy Adults 18 to ≤49 Years of AgeCompletedNCT05096208Phase 3Results posted
- STUDY TO EVALUATE THE EFFECT OF PF-06882961 ON SINGLE DOSE ATORVASTATIN, MEDAZOLAM AND ORALCONTRACEPTIVE PHARMACOKINETICS IN HEALTHY ADULT PARTICIPANTSCompletedNCT05093205Phase 1Results posted
- MagnetisMM-4: Umbrella Study of Elranatamab (PF-06863135) in Combination With Anti-Cancer Treatments in Multiple MyelomaTerminatedNCT05090566Phase 2Results posted
- This Study is to Describe and Evaluate Patients in Finland Treated With Tofacitinib for the Treatment of Ulcerative Colitis Using Real World Data.CompletedNCT05082428Results posted
- Generate Real World Data On Tofacitinib Induction Therapy and Changes In Clinical and Patient Reported Outcomes.TerminatedNCT05069259Results posted
- A Study of PF-07260437 in Advanced or Metastatic Solid TumorsTerminatedNCT05067972Phase 1Results posted
- A Study to Estimate the Effect of Multiple Dose Abrocitinib on Caffeine, Efavirenz, and Omeprazole in Healthy ParticipantsCompletedNCT05067439Phase 1Results posted
- PF-07321332/Ritonavir and Ritonavir on Dabigatran Study in Healthy ParticipantsCompletedNCT05064800Phase 1Results posted
- A Study To Estimate The Effect of PF-06650833 On The Pharmacokinetics (PK) of Oral Contraceptive (OC)CompletedNCT05064332Phase 1Results posted
- Study of PF-07263689 in Participants With Selected Advanced Solid TumorsTerminatedNCT05061537Phase 1Results posted
- Etrasimod Dose-Ranging Versus Placebo as Induction Therapy Study in Adult Japanese Subjects With Moderately to Severely Active Ulcerative ColitisCompletedNCT05061446Phase 2Results posted
- A Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Modified RNA Vaccine Against InfluenzaCompletedNCT05052697Phase 1/2Results posted
- Study to Investigate the Mass Balance, Metabolism, and Excretion of [14C]-PF-07304814 in Healthy ParticipantsCompletedNCT05050682Phase 1Results posted
- A Study of a Potential Oral Treatment to Prevent COVID-19 in Adults Who Are Exposed to Household Member(s) With a Confirmed Symptomatic COVID-19 InfectionCompletedNCT05047601Phase 2/3Results posted
- A Single Dose Study To Test Two Pediatric Forms Of Ritlecitinib Compared With Adult Ritlecitinib In Healthy AdultsCompletedNCT05040295Phase 1Results posted
- Investigation of Safety, Tolerability, Immunogenicity and Pharmacokinetics of Single-Dose of PF-06823859 in Japanese Healthy ParticipantsCompletedNCT05037409Phase 1Results posted
- Drug-Drug Interaction Study to Estimate the Effect of PF-07321332/Ritonavir and Ritonavir on Midazolam in Healthy ParticipantsCompletedNCT05032950Phase 1Results posted
- Evaluation of the Relative Bioavailability of Bosutinib Capsules Under Fed Condition and Estimation of Food Effect on Orally Administered Bosutinib CapsuleCompletedNCT05032690Phase 1Results posted
- Treatment Patterns and Bleeding Risk of Anticoagulants in Patients With Venous Thromboembolism in KoreaCompletedNCT05022563Results posted
- COVID-19 Vaccination and Breakthrough Infections Among Persons With Immunocompromising Conditions in the United StatesCompletedNCT05020145Results posted
- A Study to Learn About the Study Medicine (Elranatamab) in Participants With Multiple Myeloma That Has Come Back After Responding to Treatment or Has Not Responded to TreatmentCompletedNCT05014412Phase 2Results posted
- Current Treatment Outcomes in Japanese RCC Patients Treated With Avelumab Plus Axitinib as First-line Therapy: Retrospective Study (J-DART)CompletedNCT05012865Results posted
- Comparative Real World Tumor Response in Pre-menopausal Metastatic Breast Cancer Patients Treated With Palbociclib + Aromatase Inhibitor or Aromatase Inhibitor AloneCompletedNCT05012644Results posted
- Evaluation of Protease Inhibition for COVID-19 in Standard-Risk Patients (EPIC-SR).TerminatedNCT05011513Phase 2/3Results posted
- Study to Estimate the Effects of Hepatic Impairment on the Pharmacokinetics (PK) of PF-07321332CompletedNCT05005312Phase 1Results posted
- A Study to Learn About the Study Medicine (Called Ontorpacept or TTI-621) Given Alone and in Combination With Doxorubicin in People With LeiomyosarcomaTerminatedNCT04996004Phase 2Results posted
- A Study of SEA-CD40 Given With Other Drugs in CancersCompletedNCT04993677Phase 2Results posted
- Safety and Efficacy Active Drug vs. Placebo in Subjects With AsthmaTerminatedNCT04987944Phase 1Results posted
- Real-World Outcomes of US Talazoparib-Treated Patients With Locally Advanced or Metastatic Breast CancerCompletedNCT04987931Results posted
- A Study to Evaluate GBT021601-012 Single Dose and Multiple Dose in Participants With Sickle Cell Disease (SCD)CompletedNCT04983264Phase 1Results posted
- Study to Evaluate Clinical Real World Outcomes of Lorlatinib After Alectinib in ALK-Positive NSCLC Japanese PatientsCompletedNCT04979988Results posted
- Study to Assess the Pharmacokinetics, Safety and Tolerability of Aztreonam-Avibactam in Healthy Chinese Participants.CompletedNCT04973826Phase 1Results posted
- Pivotal Bioequivalence Study to Qualify Manufacturing Site Transfer for Prazosin Hydrochloride CapsulesCompletedNCT04967443Phase 1Results posted
- Drug-Drug Interaction Study Assessing Effect of Carbamazepine on PF-07321332 Boosted With RitonavirCompletedNCT04962230Phase 1Results posted
- Drug-Drug Interaction Study Assessing Effect of Itraconazole on PF-07321332/Ritonavir in Healthy ParticipantsCompletedNCT04962022Phase 1Results posted
- EPIC-HR: Study of Oral PF-07321332/Ritonavir Compared With Placebo in Nonhospitalized High Risk Adults With COVID-19CompletedNCT04960202Phase 2/3Results posted
- Treatment Patterns & Clinical Outcomes of Palbociclib Combinations in HR+HER2-MBCCompletedNCT04937660Results posted
- A Study to Assess the Safety and Efficacy of Inclacumab in Participants With Sickle Cell Disease Experiencing Vaso-occlusive CrisesCompletedNCT04935879Phase 3Results posted
- Oxbryta® Product Registry An Observational Study Designed to Evaluate the Effect of Oxbryta in Individuals With SCDTerminatedNCT04930445Results posted
- Study to Assess Efficacy and Safety of PF-06947386 in Japanese Adult Patients With Complicated Intra-abdominal InfectionCompletedNCT04927312Phase 3Results posted
- A Study of a Single Dose of Inclacumab to Reduce Re-admission in Participants With Sickle Cell Disease and Recurrent Vaso-occlusive CrisesTerminatedNCT04927247Phase 3Results posted
- A Study To Investigate The Pharmacokinetics, Pharmacodynamics, Safety And Tolerability Of Single Dose Vupanorsen In Healthy Chinese AdultsCompletedNCT04916795Phase 1Results posted
- Bioavailability of Bosutinib Administered as Capsule Contents Mixed With Applesauce or Yogurt Relative to Intact Capsules Under Fed ConditionCompletedNCT04916769Phase 1Results posted
- A Study to Assess the Effect of Oral Temanogrel on Digital Blood Flow in Adult Participants With Raynaud's Phenomenon Secondary to Systemic SclerosisTerminatedNCT04915950Phase 2Results posted
- Renal Impairment Study of PF-07321332 Boosted With Ritonavir in Adult Participants With Renal Impairment and in Healthy Participants With Normal Renal Function.CompletedNCT04909853Phase 1Results posted
- A Study Evaluating Relative Bioavailability of an Oral Suspension of Abrocitinib and Effect of an Acid Reducing Agent on the Bioavailability of Abrocitinib and Assessing the Taste of Abrocitinib Oral Formulations.CompletedNCT04903093Phase 1Results posted
- Trial to Describe the Safety, Tolerability, and Immunogenicity of Trumenba When Administered to Immunocompromised Participants ≥10 Years of AgeCompletedNCT04893811Phase 4Results posted
- A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of PF-06882961 in Chinese Adults With Type 2 Diabetes MellitusCompletedNCT04889157Phase 1Results posted
- Safety and Immunogenicity Study of 20vPnC When Coadministered With a Booster Dose of BNT162b2CompletedNCT04887948Phase 3Results posted
- Efficacy and Safety of CAZ-AVI in the Treatment of Infections Due to Carbapenem-resistant G- Pathogens in Chinese AdultsCompletedNCT04882085Phase 4Results posted
- Special Investigation of COMIRNATY in the Population With Underlying DiseasesCompletedNCT04880447Results posted
- Study to Evaluate Safety and Tolerability of a Single Dose of PF-06741086 in Chinese Adult Participants With Severe HemophiliaCompletedNCT04878731Phase 1Results posted
- 20-valent Pneumococcal Conjugate Vaccine Safety and Immunogenicity Study in Pneumococcal Vaccine-Naïve Adults 60 Years of Age and Older in Japan, Korea, and TaiwanCompletedNCT04875533Phase 3Results posted
- A Study in Healthy Adult Male Participants to Assess Absorption, Distribution, Metabolism and Excretion (ADME) of Radiolabeled PF-06865571.CompletedNCT04866225Phase 1Results posted
- Study to Evaluate the Safety, Local and Systemic Tolerability, and Pharmacokinetics of Multiple-Dose Topical Administration of PF-07038124 in Japanese Healthy ParticipantsCompletedNCT04863417Phase 1Results posted
- Study in Healthy Adults Evaluating PF-07202954CompletedNCT04857437Phase 1Results posted
- A Study Evaluating the Safety, Tolerability, and Effect on Microvascular Obstruction of Intravenous Temanogrel in Adult Participants Undergoing Percutaneous Coronary InterventionTerminatedNCT04848220Phase 2Results posted
- Continuation Study of B1371019(NCT03416179) and B1371012(NCT02367456) Evaluating Azacitidine With Or Without Glasdegib In Patients With Previously Untreated AML, MDS or CMMLCompletedNCT04842604Phase 3Results posted
- A Drug-Drug Interaction Study Between PF-06882961 and PF-06865571 in Healthy Adult Participants and Overweight Adults or Adults With Obesity Who Are Otherwise HealthyCompletedNCT04839393Phase 1Results posted
- The Effect Of Tafamidis Meglumine In Transthyretin Amyloid Polyneuropathy PatientsCompletedNCT04828993Phase 4Results posted
- Monitoring Activity And Gait In ChildrenCompletedNCT04823650Results posted